DR. PENDLETON BREWSTER WICKERSHAM M.D. NPI 1053380048

NPI Information

  • NPI: 1053380048
  • Provider Name: DR. PENDLETON BREWSTER WICKERSHAM, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 4511 HORIZON HILL BLVD
    SUITE 150
    SAN ANTONIO, TX
    ZIP 78229
  • Phone: (210) 477-2626

Map and Directions

Get Directions

NPI Details

DR. Pendleton Brewster Wickersham, M.D. is a rheumatology internal medicine in San Antonio, TX with 25 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Pendleton Brewster Wickersham, M.D. NPI is 1053380048. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: BAYLOR COLLEGE OF MEDICINE
Graduation Year:2000

The provider's business location address is:

4511 HORIZON HILL BLVD
SUITE 150
SAN ANTONIO, TX
ZIP 78229-263
Phone: (210) 477-2626
Fax: (210) 477-2650

The NPI 1053380048 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, anifrolumab-fnia, 1 mg (HCPCS:J0491)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, rituximab, 10 mg (HCPCS:J9312)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
  • Vitamin d-3 level (HCPCS:82306)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
  • Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
  • Measurement of dna antibody, native or double stranded (HCPCS:86225)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Tuberculosis test, gamma interferon (HCPCS:86480)
  • Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose (HCPCS:J7323)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
  • Rheumatoid factor level (HCPCS:86431)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Measurement of antibody for assessment of autoimmune disorder, titer (HCPCS:86039)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • X-ray of hand, 2 views (HCPCS:73120)
  • Thyroxine (thyroid chemical), total (HCPCS:84436)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Thyroid hormone evaluation (HCPCS:84479)
  • Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
  • Parathormone (parathyroid hormone) level (HCPCS:83970)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Uric acid level, blood (HCPCS:84550)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Liver function blood test panel (HCPCS:80076)
  • Injection of trigger points, 3 or more muscles (HCPCS:20553)
  • X-ray of knee, 1-2 views (HCPCS:73560)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Blood creatinine level (HCPCS:82565)
  • Calcium level, total (HCPCS:82310)
  • Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
  • Unclassified biologics (HCPCS:J3590)

The enumeration date for this NPI number is 3/14/2006 and was last updated on 2/1/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatologyM3113TEXASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
18F5158MEDICARE PINTEXAS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.